28 October 2021
The European Parliament and EU Member States have struck a deal to strengthen the role of the European Medicines Agency (EMA) in crisis management, after the COVID-19 pandemic caused severe shortages of medicines and medical equipment.
16 September 2021
Today the European Commission created a new authority (HERA - European Health Emergency Preparedness and Response Authority) to avoid some of the frailties that the COVID pandemic cruelly exposed in early 2020, when supply chains were severely disrupted and there were shortages of medicines in intensive care units and protective equipment such as masks.
08 July 2021
The European Parliament has voted to give greater powers to the European Medicines Agency (EMA) to help it better manage public health crises and improve access to critical medicines and medical devices for consumers.
Our work areas
As consumers are faced with a growing amount of information from different sources, we advocate for high quality and non-promotional information about health products.
The ageing of the population, rising healthcare costs and the economic crisis are challenging the sustainability of healthcare systems and consumers’ access to treatments.
Health scandals such as the weight-loss drug Mediator and the faulty PIP breast implants keep undermining consumers’ confidence in the safety of available health products and their oversight by the competent authorities.
- Ensure consumers have access to high quality healthcare in all EU Member States
- Guarantee consumers benefit from safe and innovative treatments
- Allow consumers to make informed choices regarding their health